Yoshiyuki Onishi
R&D Division And Technology Division
Tokyo, Japan
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Design, synthesis, and biological properties of novel metabolizable pH-responsive lipids for use in lipid nanoparticles for siRNA delivery and mRNA vaccination.
Journal: Nucleosides, nucleotides & nucleic acids
Published: January 17, 2026
Not all 2',4'-bridged modifications stabilize DNA/RNA duplexes.
Journal: Nucleosides, nucleotides & nucleic acids
Published: July 10, 2023
Renadirsen, a Novel 2'OMeRNA/ENA® Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo.
Journal: Current issues in molecular biology
Published: August 02, 2021
An improved synthesis of 2'-O,4'-C-ethylene nucleic acid (ENA) and thermodynamic studies of duplex formation containing the guanosine ENA unit.
Journal: Nucleosides, nucleotides & nucleic acids
Published: January 31, 2020
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5.
Journal: Nature communications
Published: May 05, 2019
Discovery of DS-6930, a potent selective PPARγ modulator. Part I: Lead identification.
Journal: Bioorganic & medicinal chemistry
Published: July 20, 2018
Discovery of DS-6930, a potent selective PPARγ modulator. Part II: Lead optimization.
Journal: Bioorganic & medicinal chemistry
Published: July 20, 2018
Detection of Dystrophin Dp71 in Human Skeletal Muscle Using an Automated Capillary Western Assay System.
Journal: International journal of molecular sciences
Published: April 26, 2018
Alkylsulfanyl analogs as potent α2δ ligands.
Journal: Bioorganic & medicinal chemistry letters
Published: March 23, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026